| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,289 |
15,380 |
$2.97M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,549 |
13,011 |
$1.99M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,915 |
7,101 |
$683K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,182 |
2,907 |
$371K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,302 |
3,045 |
$326K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,152 |
2,085 |
$271K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,633 |
1,485 |
$261K |
| 97597 |
|
1,548 |
741 |
$211K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
726 |
635 |
$145K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,256 |
1,222 |
$145K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
455 |
448 |
$112K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,034 |
261 |
$80K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
232 |
129 |
$68K |
| A0425 |
Ground mileage, per statute mile |
827 |
691 |
$67K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,037 |
352 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
1,457 |
1,375 |
$54K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,546 |
1,519 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,547 |
1,519 |
$40K |
| 80053 |
Comprehensive metabolic panel |
9,891 |
8,815 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
709 |
640 |
$29K |
| 90837 |
Psychotherapy, 53 minutes with patient |
161 |
107 |
$28K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,827 |
1,279 |
$27K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
179 |
176 |
$20K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
53 |
49 |
$17K |
| 86900 |
|
530 |
519 |
$17K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
346 |
336 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,250 |
16,326 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,352 |
1,320 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,493 |
3,237 |
$13K |
| 95811 |
|
13 |
12 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,929 |
1,785 |
$11K |
| 36592 |
|
2,630 |
2,366 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
597 |
546 |
$9K |
| 86850 |
|
511 |
503 |
$8K |
| 86901 |
|
530 |
519 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
247 |
233 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
12,129 |
11,023 |
$6K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
238 |
235 |
$6K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
274 |
267 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
42 |
41 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13 |
12 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,828 |
2,475 |
$4K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
16 |
16 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
110 |
99 |
$3K |
| 84145 |
|
686 |
644 |
$3K |
| 86803 |
|
263 |
253 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
422 |
401 |
$3K |
| 85379 |
|
360 |
340 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
13 |
$2K |
| 86480 |
|
37 |
36 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
12 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
152 |
146 |
$2K |
| 81001 |
|
6,356 |
5,967 |
$2K |
| 87430 |
|
757 |
743 |
$1K |
| 83880 |
|
103 |
91 |
$1K |
| 86780 |
|
140 |
133 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$1K |
| 83690 |
|
1,655 |
1,544 |
$884.90 |
| 83605 |
|
681 |
614 |
$878.02 |
| 87070 |
|
56 |
56 |
$843.39 |
| 84484 |
|
1,249 |
1,039 |
$833.41 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
51 |
50 |
$743.11 |
| 87631 |
|
41 |
41 |
$636.00 |
| 80076 |
|
117 |
104 |
$570.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
878 |
815 |
$550.80 |
| 82607 |
|
37 |
37 |
$541.55 |
| 86704 |
|
36 |
35 |
$433.30 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
36 |
35 |
$397.28 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
15 |
15 |
$387.83 |
| 86140 |
|
1,299 |
1,208 |
$348.20 |
| 36591 |
|
47 |
27 |
$316.08 |
| 82248 |
|
1,060 |
993 |
$304.17 |
| 87340 |
|
49 |
47 |
$282.08 |
| 87081 |
|
65 |
63 |
$207.95 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29 |
27 |
$178.20 |
| 86706 |
|
16 |
16 |
$171.68 |
| 87040 |
|
20 |
14 |
$157.75 |
| 87077 |
|
14 |
13 |
$152.61 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
93 |
78 |
$138.64 |
| Q3014 |
Telehealth originating site facility fee |
14 |
13 |
$122.38 |
| 83735 |
|
490 |
459 |
$111.01 |
| 86762 |
|
29 |
27 |
$106.50 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
74 |
37 |
$96.22 |
| 82077 |
|
140 |
121 |
$95.59 |
| 82570 |
|
21 |
13 |
$57.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
148 |
138 |
$52.43 |
| 84450 |
|
37 |
34 |
$41.44 |
| 84460 |
|
37 |
34 |
$37.11 |
| 85730 |
|
52 |
49 |
$30.60 |
| 80143 |
|
15 |
14 |
$26.97 |
| J2704 |
Injection, propofol, 10 mg |
12 |
12 |
$25.65 |
| 85610 |
|
101 |
93 |
$21.85 |
| 85049 |
|
15 |
14 |
$17.92 |
| 80306 |
|
79 |
73 |
$16.93 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12 |
12 |
$15.29 |
| 80179 |
|
15 |
14 |
$13.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$12.83 |
| 82550 |
|
40 |
35 |
$6.83 |
| 82962 |
|
45 |
40 |
$3.24 |
| 82140 |
|
14 |
14 |
$0.00 |
| A9270 |
Non-covered item or service |
73 |
62 |
$0.00 |
| 74019 |
|
16 |
14 |
$0.00 |
| 85652 |
|
15 |
12 |
$0.00 |
| 85027 |
|
26 |
26 |
$0.00 |
| 83615 |
|
20 |
18 |
$0.00 |